Longaeva Partners L.P. Edwards Lifesciences Corp Transaction History
Longaeva Partners L.P.
- $490 Billion
- Q2 2025
A detailed history of Longaeva Partners L.P. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Longaeva Partners L.P. holds 257,350 shares of EW stock, worth $19.6 Million. This represents 4.11% of its overall portfolio holdings.
Number of Shares
257,350Holding current value
$19.6 Million% of portfolio
4.11%Shares
1 transactions
Others Institutions Holding EW
# of Institutions
1,449Shares Held
485MCall Options Held
2.76MPut Options Held
1.54M-
Vanguard Group Inc Valley Forge, PA70MShares$5.32 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.88 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$1.95 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY22MShares$1.67 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA19.8MShares$1.51 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $47B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...